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ABSTRACT 
 
Introduction: South Africa has an appreciable burden of both communicable and non-communicable 
diseases as well as high maternal, neonatal and child morbidity. There have been significant strides 
with improving the public health system, and addressing current inequalities, in recent years with the 
right to health a constitutional provision in South Africa. Initiatives include the introduction of National 
Health Insurance (NHI), programmes to enhance access to medicines for patients with chronic 
diseases, as well as activities to improve care in hospitals including improving pharmacovigilance. 
Consequently, the objective of this paper is to review ongoing initiatives within the public healthcare 
sector in South Africa and their influence to provide future direction. Method: Principally a structured 
review of current and planned activities. Results: There have been a number of major activities and 
initiatives surrounding the availability and access to medicines in the public system in recent years in 
South Africa. This includes a National Surveillance Centre and an innovative early warning system for 
the supply of medicines as well as the development of a National Health Care Pricing Authority and 
initiatives to improve contracting. There have also been developments to improve the supply chain 
including instigating Medicine Procurement Units in the provinces and enhancing forecasting 
capabilities. Access to medicines is improving though the instigation of stable chronic disease 
management initiatives to increase the number of external pick-up points for medicines. There are 
also ongoing programmes to enhance adherence to medicines as well as enhance adherence to 
Standard Treatment Guidelines and Essential Medicines Lists with their increasing availability. In 
addition, there is a movement to enhance the role of health technology assessment in future decision 
making. Hospital initiatives include increased focus on reducing antimicrobial resistance through 
instigating stewardship programmes as well as improving adverse drug reaction reporting and 
associated activities. Conclusion: Overall, there are an appreciable number of ongoing activities within 
the public health system in South Africa to try and ensure and sustain universal healthcare. It is too 
early to assess their impact, which will be the subject of future research.  
 
Key words: chronic disease management, contracting, health care reforms, medicines 
pharmacovigilance, procurement, South Africa, Standard Treatment Guidelines, supply chain 
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1. INTRODUCTION 
 
South Africa has extended the share of gross domestic product (GDP) to health over the past two 
decades. In 1995, 7.42% of GDP was spent on health, whilst currently South Africa spends 8.5 ± 
8.9% of its GDP on health (Department Health 2015, Jakovljevic et al., 2017), with pharmaceuticals 
an estimated 10 to 15% of this. However, there is currently a marked inequality to medicine access in 
the country, with private health care consuming the majority of medicines for a minority of the 
population (Table 1). Increasing income disparities amongst citizens, and growing out of pocket 
expenses for health care ($67 per capita in 1995 vs. $80 per capita in 2013 adjusted for purchasing 
price parity), are challenges to equitable and affordable health care for all (Jakovljevic et al., 2017).  
As the right to health is a constitutional provision in South Africa, there has been a strive towards 
universal health coverage (UHC) and a unified health system to improve equitable access to 
medicines to the population as a whole (Department Health, 2012; Sekhejane 2013; Department 
Health, 2015; Jakovljevic et al., 2017; Perumal-Pillay and Suleman, 2017a; Perumal-Pillay and 
Suleman, 2017b). Currently, South Africa is considered the flagship national health system in sub-
Sahara Africa (Jakovljevic et al., 2017), with its National Department of Health (NDoH) moving 
towards UHC with the introduction of the National Health Insurance (NHI) initiative (Department 
Health, 2015; Perumal-Pillay and Suleman, 2017a). This is likely to continue, certainly in the short to 
medium term. 
 
TABLE 1 An overview of the South African healthcare system (Jobson, 2015; Department Health, 
2016; Econex, 2016; Jakovljevic et al., 2017; Perumal-Pillay and Suleman, 2017b) 
  
 SOUTH AFRICAN HEALTHCARE SYSTEM 
Public healthcare Private healthcare 
Funding Government Individuals or medical insurance 
Hospital capacity ± 87 141 beds  ± 34 600 beds 
Population served 82.5 - 84% (42 million); each public 
healthcare clinic providing care for 
on average 13 718 patients 
17.5% (8.2 million)  
Expenditure per 
capita on health in 
2013 (current 
US$PPP) 
US$543 US$578 
Total health 
expenditure 
(current US$PPP 
and million 
constant 2005US$)) 
US$28,000 US$31,320 
Health information 
system 
Mostly paper based systems; 
currently changing 
Electronic based system 
ZAR: South African Rand 
 
The current population of South Africa is estimated at 55.91 million, 51% female, predominantly 
young with 30.1% younger than 15 years and a median age of 25.9 years (Statistics South Africa, 
2016). However, after death rates peaked between 2003 and 2005, this is changing with an upward 
trend in life expectancy, mainly attributable to the marked reduction in mortality from HIV and AIDS 
with improved treatments and high adherence rates generally in sub-Sahara Africa (Binagwaho and 
Ratnayake, 2009; Ware et al., 2009; Wang et al., 2016a; NDoH, 2017a). 
 
Sub-Saharan Africa still has the highest burden of infectious disease in the world, with one of four 
communicable diseases, HIV/ AIDS, malaria, lower respiratory infections or diarrhoeal diseases 
currently leading causes of years of life lost due to premature mortality (Lim SS et al., 2016; Wang et 
al., 2016a; Wang et al, 2016b; Fullman et al, 2017). Within sub-Sahara Africa, South Africa still has 
one of the highest burdens, with a high prevalence of HIV and AIDS, as well as tuberculosis, resulting 
in South Africa (SA) currently being 122 out of 188 countries in terms of Sustainable Development 
Goals in 2016 (Wang et al, 2016b; Fullman et al., 2017). It is estimated in South Africa that 7.03 
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million patients currently have HIV/ AIDS, with a prevalence rate of 12.7% in 2016, although this can 
be as high as 8.4 million (Statistics South Africa, 2016; Wang et al, 2016b).  However, improved 
access to, and uptake of, antiretroviral (ARV) treatment, has enabled HIV positive patients in South 
Africa to live longer and healthier lives, resulting in a gradual decline in AIDS-related deaths in recent 
years (Pillay-van Wyk et al, 2016; SAMRC, 2016; Kabudula et al., 2017; Wang et al., 2016). 
   
There is also a high prevalence of sexually transmitted infections (STIs) among women in SA, estimated 
at 13%, with an incidence rate of 20 per 100 women years (Naidoo et al, 2014; Matsitse et al, 2017). 
Furthermore, there are increasing concerns with the growth of antimicrobial resistance (AMR) in SA 
including multidrug resistant bacteria, fungi, HIV and tuberculosis (Paruk et al., 2012). South Africa has 
responded through the development of a national AMR strategy (NDoH, 2015a), which is being put into 
action through the national implementation plan (NDoH, 2015b). This is starting to be addressed 
through the training of all provincial health care workers on antimicrobial stewardship practices, run by 
two national training centres (Mendelson and Matsoso, 2015; Sooruth et al., 2015, SAASP, 2017), with 
regional AMR committees now being established.  
 
There has also been a rise in non-communicable diseases (NCDs) in SA in recent years, similar to 
other BRIC countries as well as global trends (Adebolu and Naidoo, 2014; Jakovljevic and 
Milovanovic, 2015;  Kabudula et al., 2017; NCD-RisC, 2017; Rampamba et al., 2017). Overall, up to 
78% of people aged 50 or over have hypertension in South Africa, resulting in hypertension being the 
seventh cause of death and a major contributor to cardiovascular disease in South Africa (Lloyd-
Sherlock et al., 2014; Statistics South Africa, 2015). In addition, with up to 70% of women and a third 
of men are currently overweight or obese in SA (Cois and Day, 2015).  
 
Consequently, health care in South Africa is faced with major challenges arising from a high burden of 
disease including HIV and AIDS (Wang et al, 2016b), tuberculosis (TB), high maternal, neonatal and 
child morbidity, high levels of trauma and violence, and growing rates of NCDs (Adebolu and Naidoo, 
2014; Naidoo et al, 2014; Jakovljevic and Milovanovic, 2015; Lalkhen and Mash, 2015; Fullman et al, 
2016; SAMRC 2016). These challenges have a profound effect on the health of the SA population, as 
the country works towards the goal of universal and equitable access to healthcare for all citizens 
(Department Health 2015). The growing burden of NCDs furthermore necessitates health system 
reform, moving the focus away from prioritising acute care towards managing complex chronic diseases 
(Jakovljevic and Milovanovic, 2015). 
 
Initiatives surrounding the NHI build on existing national medicines policies and the Standard 
Treatment Guidelines (STGs) and Essential Medicine List (EML), which have been implemented in 
South Africa since 1996 (Perumal-Pillay and Suleman, 2016; Matsitse et al., 2017, Perumal-Pillay and 
Suleman, 2017a; Perumal-Pillay and Suleman 2017b).   
 
Alongside this, there has been the implementation of the Central Chronic Medicine Dispensing and 
Distribution (CCMDD) programme in South Africa since 2014 to improve access to chronic medicines 
and enhance patient experiences given the increasing prevalence of NCDs (Department Health 2015; 
Department Health KZN, 2016a; Perumal-Pillay and Suleman, 2017a). However, there continues to 
be concern over the level of education of patients and the subsequent impact on adherence to the 
medicines provided (WHO, 2013; Adebolu and Naidoo, 2014, Nielsen et al., 2017, Rampamba et al., 
2017). It is anticipated that improving adherence rates to treatment regimens should reduce morbidity 
and mortality from NCDs such as cardiovascular disease (Krousel-Wood et al., 2004; Calhoun et al., 
2008, Nielsen et al., 2017).  Patient adherence to treatment regimens can also be enhanced through 
improving patient knowledge and monitoring their care (Moosa et al., 2016; Nielsen et al., 2017), with 
ongoing initiatives to address this including the potential use of diaries and smart phone adherence 
applications given the increasing use of smart phones in South Africa (Africanews, 2016).  
 
Since 2011, a concentrated effort has been made by the South African NDoH to ensure quality 
healthcare delivery at all levels of care, with the publication of the National Quality Standards for Health, 
based on seven domains and six priority National Core Standards (NDoH, 2014). The public health 
domain stipulates how health facilities should function together with local communities and relevant 
sectors, to promote health, prevent illness and reduce further complications; and ensure that integrated 
and quality care is provided for their whole community. The patient safety, clinical governance and 
clinical care domains provide quality criteria to ensure quality nursing, clinical care and ethical practice; 
how to reduce unforeseen harm to healthcare users or patients in identified cases of greater clinical 
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risk; how to prevent or manage problems or adverse events; and support any affected patients or  staff 
(Sekhejane, 2013).  
 
Quality standards are also provided for infection control, clinical support services and measures to 
enhance the prescribing of medicines according to treatment guidelines (NDoH, 2014). In the future, all 
health facilities must be fully compliant with national norms and standards to be accredited for providing 
services within the NHI. These norms and standards are regularly updated and are now promulgated 
as regulations to the National Health Amendment Act, 2003 (Act No. 61 of 2003) (NDoH, 2017b).  
 
There is growing evidence that access to high-quality health care substantially improves health 
outcomes for patients including those with infectious diseases, maternal health, cancers and NCDs 
(Barber RM et al, 2017). Access and quality are important priorities for UHC, moving towards achieving 
identified Sustainable Development Goals (SDGs) (Barber RM et al., 2017; Fullman N et al., 2017). 
Consequently, quantifying the extent to which personal health care and access can improve population 
health, and ultimately health-system performance, is an important priority. However, at this stage, the 
6'*¶V UHC target is focused mainly at tracer interventions in areas of maternal and child health, 
reproductive health, and a subset of infectious diseases, without adequately recognising the essential 
role of personal health care in combating NCDs and injuries (Limm SS et al; 2016; Barber RM et al., 
2017; Fullman N et al., 2017). One way forward is to quantify personal health-care access and quality 
(HAQ) (2017), with changes in the HAQ Index over time indicating where personal health-care access 
and quality have improved in parallel with changes in development. In the case of SA, although there 
has been a marked improvement in the HAQ Index since 1990, the research shows that greater gains 
in personal health-care access and quality should still be possible given SA¶V SODFH ZLWKLQ WKH
development spectrum (Barbar et al., 2017).  
 
Ensuring adequate supplies of medicine, at affordable prices, is a key element of managing diseases, 
including NCDs, effectively. To ensure this, comprehensive procurement systems and robust supply 
chain management systems are essential to manage those medicines deemed essential as per the 
STGs. Functioning logistic networks will improve access to medicines, and innovative programmes to 
assess medication usage will lead to better understanding of how rationally medication is being used in 
a country, as well as ensuring sustainability (Department Health, 2012; Department Health, 2015).  
 
South Africa is continually developing and evaluating programmes to monitor the care of patients and 
to assess the use of medicines in the country, from improving antimicrobial use (Messina et al., 2015; 
Brink et al.; 2016; Messina et al., 2017), to improving functionality of Pharmaceutical and Therapeutic 
Committees (PTCs) at all health care levels (Gauteng, 2004; Matlala et al., 2017a), and ongoing 
pharmacovigilance programmes (Suleman, 2010; Mehta et al. 2014; MCC, 2016; Gauteng, 2017). 
 
Consequently, the objective of this paper is to review ongoing initiatives within the public healthcare 
sector in South Africa in recent years to improve the quality of care, the implications and influence where 
known, as well as potential future developments. As a result, to provide a platform for debating these 
issues among key stakeholders in South Africa to help improve future healthcare delivery efficiently 
given the paucity of publications assessing pharmaceutical policy in developing countries (Gray and 
Suleman, 2015).  
 
2. METHOD 
 
This is principally a structured review of current activities, and their influence and impact where known, 
rather than an extensive literature search of peer-reviewed publications. We have used similar 
approaches in previous publications (Dylst et al., 2013; Godman et al., 2013; Malmstrom et al., 2013; 
Godman et al., 2014) to provide a platform for describing and debating key issues to improve the future 
quality and efficiency of care, especially regarding medicines.  
 
3. FINDINGS 
 
There have been a number of major activities and initiatives surrounding the availability and access to 
medicines in the public system, as well as initiatives to improve patient care and safety through 
guidelines, PCTs as well as pharmacovigilance initiatives, in recent years in South Africa. These 
initiatives are expected to continue as part of attaining and maintaining good quality healthcare for all.   
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3.1 Availability and supply of medicines  
The medicine value chain plays a critical role in the overall performance of any health system. 
Consequently, there is a need to ensure patients have a dependable supply of the right medicines, 
available at the right time, in the right quantity, and at the right place.  
 
There are a number of innovations that have already been implemented in South Africa in recent years 
to improve medicine availability and access. A National Surveillance Centre and innovative early 
warning system has now been established in South Africa, with dashboards showing medicine stock 
levels at Primary Health Care (PHC) facilities, hospitals and suppliers throughout the country. This 
system uses mobile applications or electronic systems to gather information and generate warnings 
where shortages are likely to occur.  
The NDoH in South Africa has also been piloting and implementing a number of health system 
strengthening reforms, aimed at improving medicine availability and use in recent years that centre on 
five core medicine value chain functions (Figure 1), which can be further sub-divided. 
FIGURE  1 - Core medicine value chain functions 
 
 
 
The new strategies aim to achieve a continued dependable supply and reliable payment for goods 
and services, as well as improved process efficiencies and governance. These changes will assist 
South Africa in servicing the growing patient needs with the implementation of NHI in a responsive 
manner. The overall intention is also to improve the scrutiny over current medicine prices and their 
availability with the development of a National Health Care Pricing Authority, in addition to proposed 
changes in supply chain and contracting arrangements. As a result, address concerns to access and 
affordability of medicines, especially essential medicines (Perumal-Pillay and Suleman, 2017a).  
 
3.1.1 Interventions to improve contracting 
Currently in South Africa, most essential medicines are sourced through a centralised, open tendering 
process where contracts are entered into between the NDoH and suppliers of medicines, on behalf of 
all provinces. With the strategic use of market intelligence, improved competition and efficiencies 
associated with pooled volumes, low prices can be achieved (Pharasi  and Miot, 2012).  
 
3.1.1.1 Design and implementing differentiated contracting mechanisms 
Currently, the majority of pharmaceuticals are contracted through an open tendering processes in South 
Africa (Pharasi and Miot, 2012). This 'one-size-fits-all' approach is, however, not always suitable. The 
National Treasury's 2015 Supply Chain Management Review Report highlighted the need to implement 
'strategic sourcing', considering a differentiated approach to contracting that considers the strategic 
importance of the product being purchased, as well as the complexity of the supplier market 
(Department National Tresury, 2015). To sustain low medicine prices, as well as a reliable supply, the 
Selection 
Contracting 
Supply Chain 
Management 
Contract 
Management 
Medicine Use 
1 
5 
2 
4 3 
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NDoH in South Africa will be implementing an evidence-based, differentiated approach to contracting 
in consultation with the National Treasury Office of the Chief Procurement Officer (Department National 
Treasury, 2015).  
 
Revised contracting mechanisms will also be developed based on a current review. It is likely that 
different approaches to contracting will be established for different medicine 'types' to enhance the 
availability and affordability of essential medicines.  
 
3.1.1.2 Implement targeted international and local price benchmarking to ensure sustained 
affordability 
The use of price benchmarking, similar to other countries (Leopold et al., 2012), as part of a strategic 
sourcing strategy will assist the NDoH in reviewing price trends, including areas of risk and opportunity. 
This approach will be adopted as a policy tool to ensure long-term affordability of pharmaceutical 
services.  
 
3.1.2 Interventions for supply chain optimisation 
Currently, the medicine supply chain in South Africa is characterised by limited planning activities and 
outdated, duplicative processes with high variability among the provinces and districts. Additionally, 
storage infrastructure appears ill-equipped to fully service the growing disease burden and programme 
requirements of South Africa. This will change in future with a number of planned developments which 
are described below.  
 
3.1.2.1 Expand functionality of Medicine Procurement Units to oversee and manage all supply 
chain functions  
Medicine Procurement Units (MPUs) are the cornerstone of the new supply chain in SA, responsible 
for providing shared planning and operational management services regardless of medicine type, point 
of use, or methods of replenishment and distribution. 
 
Figure 2 illustrates the visibility of the MPUs. For efficient, co-ordinated services, MPUs will have full 
control and visibility for their given jurisdiction. Networks of MPUs should ultimately be able to account 
for all public sector medicine transactions. 
 
The MPUs are responsible for provincial contract management and monitoring of supply chain 
performance, with MPUs now fully implemented with conditions of contact for every supplier. The 
accuracy of any forecasting plans will be monitored by the MPUs, and ultimately at a national level, to 
improve future medicine availability and prices. 
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FIGURE 2 - Activities of the Medicine Procurement Unit 
 
  
To guide differentiated approaches to implementation of the various reforms and initiatives, a supply 
chain segmentation approach has been adopted, coordinated through the MPU. These supply chain 
'segments' will now be managed more efficiently to improve product availability.  
 
3.1.2.2 Implement collaborative Demand Forecasting and Planning processes between 
provinces  
Demand Forecasting and Planning (DFP) are the processes used to estimate patient needs using 
statistical forecasting techniques. A Demand Forecast enables the government in South Africa to 
mobilise the investments needed to meet the health needs of the population. 
 
Where medicines have been identified as needed, but have limited or no availability in South Africa, the 
Demand Forecast signals potential sales to the market, and allows suppliers to plan their investments 
and business strategies. Collaborative DFP processes will be established among the provinces in South 
Africa, with the national group overseeing its implementation. 
 
3.1.2.3 Implement Supply Planning processes 
Supply Planning initiates responses to identified requirements, outlined in the Demand Plan, and 
progresses from the current situation where facilities are typically over, or under, stocked. This will be 
overseen by the relevant MPU (Figure 2). 
 
3.1.2.4 Implement improved inventory management 
To adopt effective Supply Planning, inventory management must be improved. Processes will include 
reviewing necessary minimum infrastructure requirements for storing medicines appropriately in 
compliance with legislated norms and standards for health establishments in South Africa (NDoH, 2014; 
NDoH, 2017b), and ensuring that all health establishments are adequately resourced to comply with 
these standards.  
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3.1.2.5 Implement improved replenishment management 
Currently most public sector healthcare facilities in South Africa are replenished through a uninformed 
µpull replenishment mechanism¶, initiated by facility staff equipped with limited supply chain training. To 
address concerns with unpredictable ordering and stock levels, the MPU will provide a shared planning 
function for replenishment management, with the aim of implementing informed push or advised pull to 
improve medicine supply. 
 
3.1.2.6 Strengthen distribution planning and differentiated physical distribution channels 
Addressing challenges with unnecessary stock levels and wastage is growing in importance in South 
Africa with the expansion of  chronic disease management programmes (Perumal-Pillay and Suleman, 
2017a; Rampamba et al., 2017), and the implementation of Test and Treat for HIV/AIDS, that was 
initiated in September 2016 (Durban, 2016). To address existing challenges, and expand the capacity 
of the supply chain, three distribution channels have been identified: 
x Direct delivery 
x Central dispensing for patients 
x Warehouse distribution 
 
Distribution planning will be introduced by the MPUs to ensure that distribution processes are 
optimised across all channels. Figure 3 illustrates some of the possible combinations of available 
channels, all of which will be overseen by the relevant MPU. Contracted suppliers will be required to 
retain specified levels of finished products to improve cash flow as well as reduce stock loss and 
damage. This will result in healthcare facilities having the peace of mind regarding stock being 
available and delivered within contractual lead times. This will be linked to demand and supply plans 
as part of an overall contract management function to improve the distribution system.  
 
FIGURE 3  - Stylised physical distribution channels 
 
 
 
 
In order to further improve the supply chain responsiveness, and improve access for patients, central 
dispensing of chronic medication to a pick-up point (PuP) convenient for the patient has already been 
introduced (Department Health, 2015), freeing healthcare workers to attend to patients who require 
acute clinical attention (see Section 3.2). Due to improved and easier access to medicines, patient 
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adherence to treatment should be improved, which will result in better health outcomes for patients with 
chronic NCDs. 
 
3.1.3 Interventions for improved Contract Management 
National contracts help leverage economies of scale to achieve price efficiencies by pooling the 
demand of all provinces. Currently, there is fragmentation in contracting due to a lack of standard 
processes and systems. A National Contract Management Unit (CMU) will monitor information 
aggregated through MPUs, who will be responsible for implementing tactical, uniform contract 
management protocols, as a shared service on behalf of the health facilities within their jurisdiction. 
The shared function between CMU & MPUs is already in place. However, it is recognised this 
development will require agile institutional processes, capable of responding to the changing market 
dynamics to improve future contracting. Processes will be helped by the fact that the information 
gathered will be used to monitor agreed performance metrics, with pertinent changes implemented to 
improve future performance if needed.  
 
The relevant MPUs will be responsible for implementing tactical, uniform contract management 
protocols, as a shared service on behalf of the health facilities within their jurisdiction.  
 
Although there are many interventions that are already underway, the complexity of the environment 
means that there is still a long way to go. Addressing root causes of current problems over the short, 
medium and long term, will require agile institutional processes, capable of responding to the changing 
market dynamics that are expected to accompany the implementation of NHI. The new strategy being 
implemented in South Africa aims to achieve a continued dependable supply and reliable payment for 
goods and services, improved process efficiencies and governance, predictable demand and reduced 
wastage. These changes will assist South Africa in servicing the growing patient needs, including those 
for NCDs, with the implementation of NHI in a responsive manner. 
 
The overall intention is to improve the scrutiny over the current prices paid for medicines in South Africa 
with the development of a National Health Care Pricing Authority (Department National Treasury, 2015) 
and a National Health Pricing Advisory Committee, which will be a ministerial advisory committee, within 
the implementation structures of the NHI (NDoH, 2017c). This is in addition to ensuring continued 
access to, and supply of, agreed medicines.  
 
3.1.4 Surveillance systems for medicines 
Surveillance systems for medicines include a visibility and analytics network, which consists of various 
dashboards including the assessment of medication availability at PHC and hospital level, and data 
triangulation, as well as prescribing data, guidelines and prices, to improve future medicine 
procurement and use.  
 
Supplier performance measurement will be derived from the South African Pharma Deliveries Data, 
with performance scorecards as outputs measuring Lead Time, On Time and In Full (OTIF) deliveries 
coupled with timely monthly reporting. In addition, a Pipeline Analysis Tool (PAT) has been developed 
with the data submitted by suppliers on a fortnightly basis. The visibility of supply versus demand from 
suppliers are reported with forward production planning for at least three months. An Age Analysis 
Tool (AAT) has also been developed with the data being supplied by suppliers giving an indication of 
outstanding debt for contracted items. The data will be triangulated with PMPU stock availability data 
as well as Hospital and Primary Health Care data to add robustness. This will now provide a proactive 
response in terms of stock outs and low stock holding to improve future supplies.  
 
By July 2016, the surveillance systems covered all 3400 PHCs in SA and two thirds of hospitals, with 
the initial focus on HIV, TB and vaccines. This is currently being expanded to other essential medicine 
items. A key lesson has been the essential need to establish a master procurement catalogue and bar 
coding system for nation-wide roll out. Barcodes are seen as essential to track medicines through the 
value chain. 
  
3.2 Access to Medicines 
 
The changing epidemiological profile of South Africa has led to an over extension of services devilered 
by public sector healthcare facilities, with subsequent enormous strain on available resources that have 
contributed towards medicine shortages and challenges in the quality of care provided. The Central 
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Chronic Medicines Dispensing and Distribution (CCMDD) programme was implemented to enhance 
access to medicines for stable patients on ARVs, patients on ARVs with co-morbidities as well as 
patients with NCDs requiring chronic therapy (Magadzire et al., 2015, Perumal-Pillay and Suleman 
2017a, Rampamba et al., 2017), with its process flows and content illustrated in Figure 4.  
 
FIGURE 4 - Flow diagram of the Central Chronic Medicines Dispensing and Distribution (CCMDD) 
process 
 
 
 
3.2.1 Phases and outcome from the implementation of the CCMDD programme 
The CCMDD programme was initially implemented in ten NHI districts in February 2014. The Western 
Cape province was not included due to the fact that they already had implemented a similar programme 
(Magadzire et al., 2015). Due to the success of the CCMDD programme (Department Health KZN 
2016b), it has since been rolled out to 46 districts across the other eight provinces. Each province has 
autonomy regarding the conditions to be managed through the CCMDD programme. 
 
According to service provider reports, more than 1.7 million patients have been registered on the 
programme in the eight provinces. The NDoH has also appointed more than 650 external pick-up points 
(PuPs). Additionally, patients can also make use of Adherence Clubs and outreach PuPs to collect 
repeat medicines, and these collection points are managed by the various facilities. As a result, access 
to, and use of, medicines within the public healthcare sector should appreciably improve.  
 
3.2.2 Available indicators 
Monthly statistics are now available to assist provinces and government in keeping track of the 
system and patients to improve future care. These include the following indicators: 
x Number of patients registered per facility/ district/province 
x Number of districts registered per province 
x Number of facilities registered per district/province 
x Number of external PuPs appointed per district/province 
 
Additional indicators include the following: 
x Number of parcels delivered per PuP or per district/ province 
x % of patients on ARVs 
11 
 
x % of patients on ARVs and comorbidities 
x % of patients on NCDs 
x % of patients collecting from external PuPs 
 
An alternative model for structured, safe, and reliable service delivery FORVHUWRDSDWLHQW¶VZRUNSODFHRU
home, is the Remote Automated Dispensing Units (RADUs) (Toit, 2017). However, only a few of these 
units are currently being piloted in South Africa, and too early to comment. In terms of future service 
delivery, the aim of this type of model is to also create a controlled method whereby chronic disease 
patients can, for example, have screening tests performed when they collect their chronic medicine 
parcels (Toit, 2017). This could be an opportunity for community pharmacies within the private 
healthcare sector to introduce an affordable model or service package, which could be purchased within 
the NHI system to improve access to medicines and healthcare (Toit, 2017). 
 
3.3 Initiatives to improve the quality and efficiency of patient care 
 
3.3.1 Standard Treatment Guidelines and Essential Medicine List  
The Standard Treatment Guidelines and Essential Medicine List (STGs-EML) have been developed in 
South Africa to ensure medicines are available which are safe, effective and cost-effective, and promote 
the rational use of medicines (Sooruth et al, 2015; Perumal-Pillay and Suleman, 2016; NDoH, 2015c; 
Perumal-Pillay and Suleman 2017b). STGs-EML have been developed for all levels of healthcare, 
namely PHC (focusing on nurse-initiated treatment), hospital level guidelines for paediatrics and adults, 
and a tertiary/quaternary EML for specialist level (Pharasi and Miot 2012), through their respective 
Expert Review Committees (ERCs). The ERCs are under the direction of the South African National 
Essential Medicines List Committee (NEMLC), and consist of key stakeholders relevant for their 
particular level of care, such as cardiologists for hospital level and nursing prescribers for the PHC level 
(Leong et al., 2015).  
 
Key principles used in the development of the STGs-EML include evidence based decision making, 
with criteria based on efficacy, safety, affordability, cost-effectiveness and implications for practice. 
Evidence and final medicine selections are peer reviewed to enhance the robustness of decision 
making. The STGs-EML are reviewed by the ERCs on a 3-yearly basis, with two opportunities in the 
process for South African healthcare workers to provide comments. Previously published in book format 
after the 3 year review process, completed chapters are now released on a mobile phone application 
(App), the EML Clinical Guide, allowing health care workers and patients immediate access to the latest 
medicines and guidelines in the public healthcare sector. This mobile application is now the primary 
reference source for healthcare workers to access the STGs-EML (Lancaster, 2016) with the increasing 
use of smart phones in South Africa. This is expected to enhance adherence to current guidelines, 
which has been variable in practice (Sooruth et al, 2015; Matsitse et al., 2017). 
 
Recommendations for new medicines to be placed on the STGs-EML are received by the ERCs from 
provincial PTCs within hospitals or from ambulatory care clinics through their district PTCs. A recent 
comprehensive publication by Perumal-Pillay and Suleman documented that in recent years the 
number of suggested medicines for PHCs within the PHC STGs-EMLs has increased whilst the number 
has decreased for adult and paediatric EMLs (Perumal-Pillay and Suleman, 2016). Comprehensive 
interviews with key members of the NEMLC ascertained that the processes have changed over the 
years to become predominantly evidence-based (Perumal-Pillay and Suleman, 2017b). The quality, 
safety and efficacy of new medicines for potential inclusion are typically considered first followed by 
cost considerations (Perumal-Pillay and Suleman, 2017b), although affordability is still a major area for 
sustainability and access to all.  
 
The development of guidelines with all key stakeholder groups can include criteria for use as well as 
criteria restricting the use of medicines to defined populations, including potential rationing criteria. The 
goal of the STGs-EML is enhanced by developing a well thought out and evidence-based list of key 
medicines, which is peer reviewed, to meet the needs of the population, similar to other countries 
including Spain, Sweden and the UK (Norman et al., 2009; Gustafsson et al., 2011; Bjorkhem-Bergman 
et al., 2013).  
 
Other healthcare systems have faced similar challenges to South Africa in terms of limited budgets and 
increased demand for healthcare (Jakovljevic et al., 2016). This has resulted in policies to enhance 
cost-effective prescribing among Western European countries, including enhancing the use of generics, 
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to help maintain universal and comprehensive healthcare across populations. This is in contrast to 
Central and Eastern European (CEE) countries with high co-payments, with more limited public 
spending (Jakovljevic et al., 2016). Such divisions have resulted in for instance appreciably lower use 
of biological medicines to treat inflammatory diseases such as rheumatoid arthritis and inflammatory 
bowel diseases among CEE versus Western European countries (Putrik et al., 2014a; Putrik et al, 
2014b; Kostic et al., 2017). The ongoing measures in South Africa, including chronic disease 
management programmes alongside NHI initiatives, should help address concerns seen among CEE 
countries.  
 
With the implementation of NHI, the NDoH will be appointing a Ministerial Advisory Committee (MAC) 
on Health Technology Assessment (HTA). This multi-disciplinary committee will provide 
recommendations to the Minister of Health on the prioritisation, selection, distribution, management and 
introduction of interventions for health promotion, disease prevention, diagnosis, treatment and 
rehabilitation (NDoH, 2017c). Part of this will include the creation of a South African HTA Agency 
(NDoH, 2017c). The MAC-HTA will be involved in both investment and disinvestment decisions, similar 
to agencies in other countries (Parkinson et al., 2015; Guerra-Junior et al., 2017). 
 
3.3.2 Integrated system approach to improve efficiency of access and care 
Improved access to medicines will in future be strengthened in terms of efficiency by the use of 
innovative technology to support the selection of medicines, formulary management, standard 
treatment regimens for prescribers, rational medicines use interventions and adherence support. An 
integrated online platform, Essential Medicines Electronic Access (EMelA), currently under 
development will be integrated with various electronic platforms, including electronic prescribing and 
dispensing tools, patient management systems and stock management systems (Figure 5).  
 
FIGURE 5 - Integrated system approach to improve efficiency of access to medicines 
 
 
 
Alongside these changes, there will be ongoing programmes to enhance compliance to the STGs. This 
includes possibly educational and other activities including pharmacists and other key stakeholders 
where there are concerns with prescribing, which is likely to include academic detailing similar to other 
countries (Costa et al, 2016).  Ongoing research programmes will include seeking ways to further 
improve compliance to prescribing guidance to improve future care where there are identified concerns 
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(Sooruth et al, 2015; Matsitse et al., 2017). Instigation of electronic prescribing and monitoring of 
prescriptions against agreed guidance will also enhance future adherence to prescribing guidance, as 
VHHQIRULQVWDQFHZLWKWKHµ:LVH/LVW¶LQ6WRFNKROP&RXQW\&RXQFLOLQ6ZHGHQ(Gustafsson et al., 2011; 
Bjorkhem-Bergman et al. 2013; Eriksen et al., 2017). 
 
3.3.3 Programmes to improve adherence and retention in care 
With growing numbers of patients accessing treatment for HIV, TB and NCDs, adherence increasingly 
becomes a challenge for all patients with chronic diseases (Rampamba et al., 2017). Despite South 
Africa having the largest ARV treatment programme in the world, with generally better adherence rates 
in sub-Sahara Africa compared with North America (Binagwaho and Ratnayake, 2009), challenges such 
as declining retention in care rates and increased drug resistance due to poor adherence among some 
patients and poor programme performance are evident (Baloyi et al, 2014; Ramdas et al., 2015; Vagiri 
et al., 2015).  
 
To address these concerns, the South African NDoH recently introduced their National Adherence 
Guidelines for Chronic Diseases including HIV, TB and NCDs to enhance treatment adherence, working 
towards Vision 2030 of the National Development Plan (Republic South Africa, 2013; NDoH, 2016). 
These guidelines aim to strengthen access to appropriate services in order to improve clinical 
outcomes, and for people with chronic diseases ensure linkage to care, retention in care, and support, 
to enhance their adherence to treatment (NDoH, 2016), with enhanced adherence improving outcomes 
(Ho et al. 2009; Corrao et al., 2011; Abegaz et al., 2017).  
 
Overall, the aim is to introduce a minimum package of interventions to support linkage to care, 
adherence and retention in care, to improve future patient outcomes. This includes standardised 
education counselling on hypertension, diabetes, TB and HIV, including child and adolescent disclosure 
counselling. In addition, alternative repeat prescription collection strategy options (see section 3.2), 
early tracing and retention in care as well as integrated management of chronic conditions involving 
multi-disciplinary groups. This will include patient adherence plans and pamphlets, adherence 
information, training files, standard operating procedures, fast track initiation counselling, and the 
setting of treatment goals (Toit, 2017). 
 
3.3.4 Antimicrobial stewardship programme 
 
There are ongoing programmes within hospitals in South Africa to instigate antimicrobial stewardship 
programmes (ASPs) to reduce antimicrobial resistance (AMR) (SAASP, 2017;  Brink et al., 2016), which 
is a growing problem worldwide (WHO, 2014; NDoH, 2015a; NDoH, 2015b; Hoffman and Outterson, 
2015; Mendelson and Matsoso, 2015; WHO, 2015). Antimicrobial stewardship refers to coordinated 
interventions designed to improve and monitor the appropriate use of antibiotics by promoting the 
selection of the optimal antibiotic agent(s), dose, duration of therapy, and route of administration.  The 
large burden of infectious diseases in South Africa, has necessitated specific antimicrobial stewardship 
goals as: optimising therapy for individual patients, preventing overuse and misuse of antibiotics and 
minimising the development of resistance at patient and community health levels (NDoH, 2015a;  
NDoH, 2015b). 
 
This increasingly includes utilising existing resources of pharmacists, registered nurses and other 
healthcare programmes to co-ordinate anti-infective management programmes and subsequently 
improve patient outcomes (Schellack et al, 2016). Major shifts in policy towards combatting AMR 
within the South African health care environment culminated in the NationaO'HSDUWPHQWRI+HDOWK¶V
SXEOLFDWLRQRI6$¶V$QWLPLFURELDO5HVLVWDQFH1DWLRQDO6WUDWHJ\)UDPHZRUN-24, published in 
October 2014 at a Ministerial Antimicrobial Resistance Summit to retain the effectiveness of available 
antibiotics (NDoH; 2015a) This is a multidisciplinary, intersectoral strategy combining human health, 
animal health and environmental health sectors, which is implemented through the Ministerial 
Advisory Committee on Antimicrobial Resistance. One of the strategic objectives of the framework 
ZDVWRµSURPRWHDSSURSULDWHXVHRIDQWLPLFURELDOVLQKXPDQDQGDQLPDOKHDOWK¶WKURXJKHQVXULQJ
access to safe, effective and affordable antimicrobials, institutionalising ASPs across sectors, and 
addressing the use of antimicrobials in animal health and crop production. This Committee is currently 
developing a series of guidance documents regarding the governance structures necessary at each 
level of care, the monitoring of antimicrobial use and resistance at health care level, and the 
appropriate use of antimicrobials at all health care levels, in human and animal health (NDoH, 2015a; 
NDoH, 2015b).  
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3DUDOOHOWRWKLVDQGDVSDUWRIWKHFRXQWU\¶VGULYHWRZDUGVTXDOLW\KHDOWKFare service delivery, specific 
antimicrobial stewardship (AMS) and infection prevention control norms and standards were finalized 
and published for public comment in the Government Gazette, with a view to becoming enforceable 
regulations in the future. The terms of reference of provincial AMR committees have been developed, 
and these committees are currently in the process of being established. 
The need for pharmacist-led ASPs was demonstrated in a recent study with analysis of 47 private 
hospitals across SA revealing that close to one in every 15 prescriptions contained inappropriately 
prescribed antibiotics requiring an intervention. The study highlighted the role pharmacists can play to 
improve future antibiotic use in SA as infectious disease-trained specialists are currently limited in 
number (NDoH 2015a; NDoH 2015b; Brink et al., 2016). Research is also being undertaken in public 
hospitals to assess the situation in this important sector (Bester et al, 2017; Schellack et al, 2017). 
Furthermore, the Committee is currently developing a national AMR and antibiotic use national 
surveillance dashboard, which includes private and public health care sector data. The South African 
Society of Clinical Pharmacy has also developed a guideline to outline the importance, role and 
purpose of pharmacists in antimicrobial stewardship programmes within South African hospitals to 
improve the use of antimicrobials. This is in addition to other strategies as part of the South African 
JRYHUQPHQW¶VQDWLRQDOVWUDWHJ\LQLWLDWLYHWRUHGXFH$05(NDoH, 2015a; NDoH, 2015b). 
 
3.3.5 Pharmaceutical and therapeutic committees 
 
It is also recognised that the role and functionality of PTCs needs to improve within the health system, 
at provincial, district, and institutional levels, in South Africa to enhance appropriate medication 
procurement and usage decisions to ensure sustainable financial practices that will improve patient 
care following the instigation of the National Drug Policy in 1996 (NDoH, 1996). In light of this, the 
National Policy for the Establishment and Functioning of Pharmaceutical and Therapeutics Committees 
in South Africa was published in 2015 (NDoH, 2015d). A guidance document with clearer directives on 
the functioning of the PTC is currently under development. PTC activities typically include dissemination 
of decisions from the National Essential Medicines List Committee meetings as well as any formulary 
management changes at their respective healthcare institutions.  
 
However, there are concerns with the level of reporting of adverse drug reactions (ADRs) and 
medication errors, as well as lack of evidence-based decision-making in formulary management 
(Suleman, 2010; Matlala et al., 2017a; Truter et al, 2017). This follows research highlighting the lack of 
reporting of ADRs within hospitals within South Africa, exacerbated by lack of knowledge of the 
processes involved (Matlala et al, 2017b; Terblanche et al., 2017a). This is perhaps not surprising with 
published research highlighting in South Africa that ADRs frequently develop whilst patients are in 
hospital (Mehta, 2011; Terblanche Meyer et al., 2017). In addition, in a study conducted among four 
adult medical wards in South Africa, estimated that ADRs contributed to the death of 2.9% of admitted 
patients (Mouton et al., 2015). The overall mortality rate was 18 per 100 admissions, with 16% of deaths 
ADR-related (Mouton et al., 2015). These factors have resulted in concerns regarding the current extent 
of pharmacovigilance activities in South Africa. However, recent studies among  South African teaching 
and secondary hospitals have shown the benefit of pharmacistV¶ interventions making it easier to detect 
adverse events, and to classify harm to a particular adverse event, to improve reporting rates and 
subsequent patient care (Müller et al, 2016; Terblanche et al, 2017b). 
 
3.3.6 Pharmacovigilance and patient safety 
 
Previously, pharmacovigilance has been seen as a relatively new science in Africa (Ampadu et al., 
2016). This has changed with an appreciable number of African countries now part of WHO 
Programmes for Drug Monitoring including South Africa (Ampadu et al., 2016). Pharmacovigilance (PV) 
activities in South Africa have been helped by the formation of a national PV working Group within the 
Medicines Council of South Africa dedicated to this (MCC, 2017), providing direction (MCC, 2012). 
There have also been regional initiatives to further improve PV and the reporting of ADR (Gauteng, 
2017).  
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However, despite these initiatives, most healthcare professionals in public hospitals in South Africa 
seem unaware of ADR reporting systems, with only a very limited number of professionals received 
training on ADR reporting, with the vast majority indicating the need for such training (Terblanche et al., 
2017). Following the recent introduction of a pharmacist-driven PV system within a public hospital in 
South Africa, the vast majority of healthcare professions now support the system (97%), with 85% 
understanding the need for ADR-reporting. This is helped by 69% now knowing there are ADR forms 
available (up from 15.2%), with 73% now knowing to whom to submit ADR reports to (up from 19%). 
Reasons for non-reporting of ADRs also decreased significantly (Terblanche et al, 2017b).  
 
To further increase access to appropriate reporting channels, access to the national ADR reporting 
forms, one for ADRs and one for the EPI programme, are now available on the EML Clinical Guide app 
(as mentioned previously). Reports submitted on this application are received by the National 
Pharmacovigilance Centre - the NDoH Pharmacovigilance Centre for Public Health Programmes. It is 
hoped this innovation will also increase ADR reporting as the use of smart phones continues to increase 
in South Africa. 
 
A SKDUPDFLVW¶V participation in the management of hospital in-patients on ARV treatment through the 
provision of pharmaceutical care has also proven to be beneficial for the identification, management 
and reporting of ADRs (Ally et al, 2015). This kind of research, and the implications for future activities 
to reduce the extent of ADRs, and their implications on patient morbidity, mortality and costs, will also 
be undertaken among public hospitals in South Africa to improve future patient care.  
 
DISCUSSION AND CONCLUSIONS 
 
There are an appreciable number of ongoing activities within the public healthcare system in South 
Africa to ensure equitable access to medicines and to improve the care of patients. This follows the 
instigation of universal access for all patients in South Africa, along with recognition of the growing 
burden of NCDs in South Africa. Appreciable strides have already been made in reducing the costs of 
medicines used in the public healthcare sector, particularly antiretroviral treatment for HIV infection. 
 
South Africa has already made some progress towards the SDGs as is evident from an analysis of the 
health-related SDG indicators based on the GBD studies (Lim SS et al, 2016; Fullman et al, 2017). 
Although SA¶VKHDOWK-related SDG index was below the median for 188 countries (46 vs. 59.3 in 2015 
and 122 out of 188 countries in 2016) (Lim SS et al, 2016; Fullman et al, 2017), progress has been 
seen for indicators such as the UHC tracer with a SDG index of 79, similar to the multi-country median. 
However, still below the UHC tracer target of 100% by 2030 (Lim SS er al, 2016). Low performance for 
indicators such as NCDs, childhood obesity, harmful alcohol use, and mortality due to self-harm and 
interpersonal violence signal suggest further interventions are still needed to improve the care of 
patients in the public healthcare system (Lim SS et al, 2016; Fullman et al, 2017).  
 
In terms of future estimation of the SDG indicators though, as well as evaluating the influence of future 
interventions, one should recognise the data gaps with these indicators (Lim SS et al., 2016). For the 
UHC tracer indicator, a set of tracer interventions are restricted to reproductive, maternal and child 
health, as well as a subset of infectious diseases. Furthermore, data on the coverage of NCD 
interventions and high-level care are limited, as the UHC tracer indicator only captures the interventions 
used and not the quality of the interventions provided. Future revisions are subsequently required as 
additional data becomes available on the delivery of interventions to improve the management of NCDs 
in SA, including the chronic disease management programmes as well as the modification of risk 
factors, with improved management of NCDs a key priority area in South Africa. 
 
Ongoing programmes to improve care in SA include the management of chronic diseases incorporating 
STGs and EML, along with programmes to make access to medicines easier for patients such as the 
CCMDD programme. In addition, programmes and activities to improve the supply chain as well as 
continue to obtain essential medicines at low prices. The instigation of central procurement practices 
ensures the department leverages economies of scale to help to a large extent to procure medicines at 
optimum prices.  There are also ongoing programmes within public hospitals in South Africa to improve 
the quality of care as well as reduce current AMR and ADR rates. Reducing AMR rates is critical with 
increasing use of antibiotics, with utilisation increasing globally by 36% between 2000 and 2010, with 
countries such as China, India, and South Africa accounting for 76% of this increase (O'Neill, 2015).  
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Increasing AMR rates pose a serious public health threat as well as increasing costs (Gandra et al., 
2014; Hoffman and Outterson, 2015; O'Neill, 2015). In the South African context, especially in the public 
sector, it is difficult to replicate resource-abundant ASP models.  Sustainable and effective ASPs largely 
depend on monitoring practices, teamwork in developing and implementing interventions, and 
organisational infrastructure. Consequently, it is critical in the SA context to utilize existing resources 
such as pharmacists, registered nurses, and other members of the health care team, to drive forward 
ASP programmes, which is already happening (SAASP, 2017). For effective ASPs in SA, it is important 
to recognize the skills within multidisciplinary teams that can support pharmacists to improve antibiotic 
prescribing practices within the South African Antimicrobial Resistance National Strategy Framework 
and its implementation (NDoH, 2015a; NDoH, 2015b). These are considerations for the future. Potential 
research activities in the community include a better understanding of key stakeholder attitudes to AMR, 
and how to develop programmes relevant to their needs to improve future antibiotic prescribing and 
dispensing.  
 
HTA will also play an increasing role in decision making in South Africa in the future to help assess 
which future technologies to invest in and which technologies to disinvest in. This will be closely 
monitored. 
 
Future monitoring of UHC progress in South Africa should combine the HAQ Index, coverage of health 
interventions, and prevalence of risk factors that can be modified through public health initiatives 
(Barber et al., 2017). This will provide a more comprehensive measure of the capacity of SA¶VKHDOWK
care system capacity to ensure personal health-care access and quality. 
 
Technology will also play a more prominent and important role in the future in SA to improve access 
and availability of medicines, and reduce wastage. As mentioned, a National Surveillance Centre and 
innovative early warning system has been established, with dashboards showing medicine stock levels 
at various levels of care throughout the country. Mobile applications or electronic systems are being 
used to collect information and to alert of possible medicine shortages. Innovative technology is also 
being used to empower health care workers to provide quality services.  The STGs and the EML are 
available as a mobile application, which also allows reporting of ADRs, reporting of stock-outs and 
provision of information about health care facilities. There are also ongoing programmes to improve the 
management of patients with NCDs including their education and monitoring of adherence to medicines 
(Rampamba et al., 2017). In addition, the NDOH will continue to interrogate innovative technologies to 
improve service delivery and the quality of care. This potentially includes how mobile applications can 
be used to enhance medicine adherence especially in environments with limited health literacy. Other 
research programmes include a better understanding of facilitators and barriers to medicine adherence. 
Consideration of the role of social capital needs to be understood better in South Africa building on 
previous research (Binagwaho and Ratnayake, 2009; Ware et al., 2009). 
 
To date, there have been limited formal evaluations of the impact of the extensive number of recent 
initiatives in SA. This is changing, and will be part of future research projects to further improve the 
quality and efficiency of prescribing in South Africa as the country strives to develop and maintain UHC 
in the face of an appreciable burden of both infectious and non-communicable diseases. Social 
determinants of health, and the causes of ill health, also need to be investigated further in South Africa 
with factors such as the level of education and medicine use knowledge substantially impacting on 
lifestyles and adherence to medicines (Rampamba et al., 2017).  
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